Improved methodology in determining melanoma mortality and selecting patients for immunotherapy.

Autor: Dixon, A. J., Steinman, H. K., Kyrgidis, A., Smith, H., Sladden, M., Zouboulis, C., Argenziano, G., Apalla, Z., Lallas, A., Longo, C., Nirenberg, A., Popescu, C., Dixon, J. B., Tzellos, T., Zachary, C., Cleaver, L., Anderson, S., Zagarella, S., Thomas, J. M.
Předmět:
Zdroj: Journal of the European Academy of Dermatology & Venereology; Jul2023, Vol. 37 Issue 7, pe843-e845, 3p
Abstrakt: Sentinel lymph node biopsy is now identified as a far less accurate method of predicting melanoma survival and selecting patients for adjuvant drug therapy. 3 Moody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature. [Extracted from the article]
Databáze: Complementary Index